France· FR:67430062
ABIRATERONE SANDOZ 1000 mg, comprimé pelliculé
A abiraterone product, registered in France by SANDOZ, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Abiraterone is registered in 18 of 19 countries.
Countries holding a registration under ATC L02BX03 (abiraterone), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 10 of them publish a price we can compare per daily dose
Abiraterone · ATC L02BX03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of abiraterone costs, country by country.
Normalised to the WHO defined daily dose (1 g), so markets compare like for like.
- France: $33.07 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Abiraterone · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$42.72
- FR France$33.07
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Manufacturer
- SANDOZ
- Country
- France (FR)
- ATC code
- L02BX03
- ATC class
- Abiraterone
- Defined daily dose
- 1 g, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093023322130 plaquettes prédécoupées unitaires aluminium OPA : polyamide orienté PVC de 1 compriméEUR 1.17
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
461 interactions on record for abiraterone.
Graded by severity as the source publishes them — 101 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Abiraterone · interactions on record
461 records
- 101 severe
- 335 moderate
- 25 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- LoperamideA07DA03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Abiraterone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaABIRATERONE MYLANMylan Pharmaceuticals Limited, Dublin
- FinlandAbirateron SandozSandoz A/S
- NetherlandsAbirateron 1A Pharma 1000 mg, filmomhulde tabletten1A Pharma GmbH
- SwitzerlandAbirateron Sandoz
- BelgiumAbiraterone Mylan 1000 mgMylan Pharmaceuticals
- PolandAbiraterone MylanMylan Pharmaceuticals Ltd
- SpainABIRATERONA MYLAN 1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULAMylan Ireland Limited
- SwedenAbiraterone Mylan 1000 mg Filmdragerad tablettMylan Pharmaceuticals Limited
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Abiral, Abirateron +pharma
- Belgium · Abirateron Eg, Abirateronacetaat Eg (Eurogenerics) Nv
- Bulgaria · Абиратерон Msn, Абиратерон Деватис
- Cyprus · Abiraterone Farmoz, Abiraterone Pharmazac
- Czechia · Abirateron Ashcure, Abirateron Pharmagen
- Germany · Abibam®, Abiranio
- Denmark · Abirateron "olpha", Abirateron "sandoz"
- Estonia · Abiraterone G.L. Pharma, Abiraterone Norameda
- Spain · Abiraterona Ashcure, Abiraterona Cipla
- Finland · Abirateron Avansor, Abirateron Devatis
- United Kingdom (Northern Ireland) · Abiraterone, Abiraterone Abdi
- Greece · Abinone, Abiprostem
- Croatia · Abirateron Alpha-Medical, Abirateron Devatis
- Hungary · Abaxan, Abirateron Galenika
- Ireland · Abiraterone, Abiraterone Aristo
- Iceland · Abirateron, Abirateron Medical Valley
- Italy · Abiraterone Abdi, Abiraterone Abdi Farma
- Liechtenstein · Abiraterone Accord, Abiraterone Mylan
- Lithuania · Abiraterone G.L. Pharma, Abiraterone Norameda
- Luxembourg · Abirateron Eg, Abiraterone Eugia
- Latvia · Abiraterone G.L. Pharma, Abiraterone Norameda
- Malta · Abiraterone Ashcure, Abiraterone Clonmel
- Netherlands · Abirateron 1a Pharma, Abirateron Abdi
- Norway · Abirateron Devatis, Abirateron Medical Valley
- Poland · Abiral, Abirateron Sun
- Portugal · Abiraterona Bluepharma, Abiraterona Eugia
- Romania · Abirateron? Lannacher, Abirateronă
- Sweden · Abirateron Devatis, Abirateron Medical Valley
- Slovenia · Abirateron Galenika, Abirateron Teva
- Slovakia · Abirateron Msn, Abirateron Pharmagen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3458533d-bbd5-4dec-b4db-bf2c887c2d2b GET /v1/drugs/3458533d-bbd5-4dec-b4db-bf2c887c2d2b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67430062",
"date_amm": "2021-07-06",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about abiraterone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.